Hepato-Pancreato-Biliary surgery is the mainstay of therapy for primary and secondary tumors (providing the only chance for long-term survival. In the last few decades, we witnessed an impressive improvement in the short and long-term outcomes in this field. The multidisciplinary peri-operative management, innovations, and advancement in diagnostic and surgical technology, as well, as the progress in the experimental and clinical protocols of neoadjuvant and adjuvant treatments, have had a direct impact on the advancements in this field.
This Special Issue will focus on the state of the art in the following: Surgical and diagnostical technological innovations; prognostic clinical, pathological, and molecular genomics that determine the management and outcome of Hepato-Pancreato-Biliary surgery due to primary or secondary tumors.
Hepato-Pancreato-Biliary surgery is the mainstay of therapy for primary and secondary tumors (providing the only chance for long-term survival. In the last few decades, we witnessed an impressive improvement in the short and long-term outcomes in this field. The multidisciplinary peri-operative management, innovations, and advancement in diagnostic and surgical technology, as well, as the progress in the experimental and clinical protocols of neoadjuvant and adjuvant treatments, have had a direct impact on the advancements in this field.
This Special Issue will focus on the state of the art in the following: Surgical and diagnostical technological innovations; prognostic clinical, pathological, and molecular genomics that determine the management and outcome of Hepato-Pancreato-Biliary surgery due to primary or secondary tumors.